test

Mark Gottlieb

@Altium Capital Management Lp

Latest period2024 - Q3ReportedManaged Assets$339.708MTotal holdings77
Assets growth rate-99.86%Assets growth rate (2-Q avg)-51.42%Continuous growth in asset value0 quarters

Portfolio positions

This chart displays the top 10 holdings in Altium Capital Management Lp's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 77 positions.

Assets under management

The assets under management (AUM) of Altium Capital Management Lp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 339.708M in assets, with a quarterly growth rate of -99.86% and a 2-quarter average growth rate of -51.42%. The portfolio is managed by Mark Gottlieb, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
ALIMAlimera Sciences Inc
Recent Activity
Exited
0%
$11.954B
2.15M shares@ $5560.0 avg price
ARGXArgenx Se
Recent Activity
Exited
0%
$9.891B
23,000 shares@ $430040.0 avg price
ASNDAscendis Pharma A S
Recent Activity
Exited
0%
$6.819B
50,000 shares@ $136380.0 avg price
CYBNCybin Inc
Recent Activity
Exited
0%
$3.781B
13.953M shares@ $271.0 avg price
RAREUltragenyx Pharmaceutical In
Recent Activity
Exited
0%
$2.877B
70,000 shares@ $41100.0 avg price
ACHVAchieve Life Sciences Inc
Recent Activity
Exited
0%
$1.017B
216,310 shares@ $4700.0 avg price
ALURAllurion Technologies Inc
Recent Activity
Exited
0%
$967.512M
969,840 shares@ $997.6 avg price
BIVIBiovie Inc
Recent Activity
Exited
0%
$793.928M
1.982M shares@ $400.51 avg price
CNTXContext Therapeutics Inc
Recent Activity
Exited
0%
$721.802M
360,001 shares@ $2005.0 avg price
RAPTRapt Therapeutics Inc
Recent Activity
Exited
0%
$610M↑ Call
200,000 shares@ $3050.0 avg price